Clinical pathway for patients with Chronic Myeloid Leukaemia: The Euriclea Project

Background and aims: The use of Tirosine Kinase Ihnibitors (TKIs) for the treatment of Chronic Myeloid Leukemia (CML) has definitely represented a turning point in the treatment of the onco-hematological diseases. Over the years, the interest of physicians, nurses, patients and caregivers has increa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Acta Biomed
Main Authors: Botti, Stefano, Gargiulo, Gianpaolo, Bombaci, Felice, Artioli, Giovanna, Cosentino, Chiara, Pignatelli, Adriana Concetta, Torino, Daniela, Lionetti, Maria Marcella, Samarani, Emanuela, Cappucciati, Lorella, Bordiga, Paola, Diodati, Antonella, Caffarri, Cristiana, Rosini, Irene, Pane, Fabrizio
Format: Artigo
Jezik:Inglês
Izdano: Mattioli 1885 2017
Teme:
Original Article: On the Patient's: Focus on Leukaemia
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357587/
https://ncbi.nlm.nih.gov/pubmed/28752827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v88i3-S.6608
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki